CRISPR Therapeutics AG financial statements, including revenue, expenses, profit, and loss

The total revenue of CRSP for the last quarter is 504.00 k USD, and it's 99.75% lower compared to the previous quarter. The net income of Q1 24 is -116.59 M USD.